This episode examines the ranitidine (Zantac) safety concerns and resulting litigation, explaining the science behind NDMA formation, regulatory actions, and what patients should know about documenting exposure and seeking medical or legal advice. We summarize key studies, recalls, and legal pathways in clear, actionable terms.


Show notes include official regulatory notices, peer-reviewed studies, and resources for reporting adverse events. This episode is educational and not a substitute for medical or legal counsel; consult a qualified professional if you have health concerns.



#ZantacLawsuit #Ranitidine #NDMA #DrugRecall #PharmaceuticalLiability #PatientSafety #MedicalLitigation #RegulatoryUpdates #LegalAwareness #ConsumerProtection

This podcast episode includes AI-generated voice content. However, it has been carefully edited, reviewed, and enhanced by a human to ensure natural tone, accuracy, and emotional touch.